Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @medicine_maker
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @medicine_maker
-
Prikvačeni tweet
Do you want to share the story behind your technology in a future issue of The Medicine Maker? In our December 2019 issue, The Medicine Maker will showcase the top 15 technologies released throughout 2019! Nominate now with the link below
#Pharma https://themedicinemaker.com/manufacture/nominate-now-for-the-medicine-maker-2019-innovation-awards …pic.twitter.com/yObVvtMIH1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As the world's largest supplier of heparin, China's ongoing African swine fever outbreak is a cause of concern, particularly for the US who rely on the porcine-derived product an anticoagulant.https://bit.ly/2tn5c9C
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
China has one of the world's largest supply of pigs. As African swine fever causes the decline of the country's stock, fear is building about the future of porcine-derived heparin.https://bit.ly/2tn5c9C
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chinks in the pharmaceutical industry’s armor have allowed fake and counterfeit drugs to becoming a significant problem. Here, we speak to Bright Simons, President
@Goldkeys, to find out how digital technologies are helping to address the problem.https://bit.ly/31dA35qHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
John Fowler, COO at Piramal Pharma Solutions, discusses the challenges CDMOs face in manufacturing these drugs.https://bit.ly/2rw18CN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Smarter solid dosage technologies cost more money, but isn’t there a better balance to be struck for the benefit of patient compliance?https://bit.ly/2S2PNFw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BASF has launched three virtual assistants for improved efficiency and effectiveness in offering customers access to real-time information and the opportunity to better navigate the regulatory landscape. Watch the full interview with David Friedinger
https://bit.ly/2RnxSce Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alessandra Vizza, Regional Business Director
@Corning talks about the benefits of these tools – and how she expects them to evolve in the coming years.https://bit.ly/2O9ErgsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Over 2 billion people worldwide don’t have sufficient access to essential medicines and health products. Many are frustrated because of the failure to help patients in meaningful ways. So how do we move forward? https://bit.ly/30V9rWG pic.twitter.com/RidXas7h6H
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Flore Laporte Fauret describes how One Vision, SGS' lab digitalization initiative is standardizing record-keeping procedures and maintaining excellence across its global network. Watch the full video below
https://bit.ly/3aCHSWD
#lifesciences#datainput#biologicsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gen Li and Jonathan Peachey both at Phesi, explain the importance of predictive analytical tools for companies struggling to keep up with ever-growing sources of data. Click below to read more:https://bit.ly/34KGLAK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
When poor medical adherence contributes to 200,000 deaths each year, what can be done to lessen the problem? Click below to read the full article:https://bit.ly/383JWFB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Christian Jones from
@NanoformF explains the opportunities for using new technologies, like nanotechnology, to reduce drug development efficiency and better medicines for patients. Watch the full video on our YouTube channel
https://bit.ly/37nTxGD
#nanomedicineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Is US pharma ready for another recession? George Chressanthis
@axtria gives his view here:https://bit.ly/2tD9qdTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With “no-deal” very much still on the table in the UK’s Brexit negotiations, find out how Merck is mitigating the risks in this interview with Frithjof Holtz. Click below to read more:https://bit.ly/2P647Kp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We spoke to Nathan Wineinger, Director of Biostatistics and Assistant Professor at Scripps Research about the state of the US' drug market and the reforms that could be made to help the US citizens. Click below to read more:https://bit.ly/2RlaeNA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
When seeking innovation, first and foremost we are looking for patient benefit.” Andrew Davies
@unisouthampton and Nigel Blackburn@CR_UK discuss the importance of patient-centricity for drug development.https://bit.ly/3aE4xlqHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It is essential that the quality of analytical methods be assured all the way from development and validation to routine use and transfer. Click below to read more:https://bit.ly/37XhMfw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In May 2019, GE Healthcare brought experts together at its Uppsala, Sweden, site for Bioprocess Days: an event to discuss the future of bioprocessing. Click below to read more:https://bit.ly/35SPYHa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”? Click below to read the full article:https://bit.ly/2OHTWgi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Inmune Bio CEO, RJ Tesi, wants to also bring the innate immune system to the fight. We asked him more about the company’s research. Click below to read more:https://bit.ly/35YeI10
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Editor: